Skip to main content
Clinical Trials/TCTR20191110003
TCTR20191110003
Not yet recruiting
未知

Vitamin D receptor polymorphism in two clinical phenotypes of chronic hepatitis B infection: HBV carrier with low viral load and chronic hepatitis phases

Department of medicine0 sites300 target enrollmentNovember 10, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Vitamin D receptor polymorphismChronic HBV infectionHBV carrier with low viral loadChronic hepatitis
Sponsor
Department of medicine
Enrollment
300
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2019
End Date
May 31, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic HBV infection defined by HBsAg positive more than 6 months.

Exclusion Criteria

  • \- pregnancy
  • \- patients with the conditions that may alter the immune system, for example; HIV infection, cancer, autoimmune disease, receiving immunosuppressive drugs and active infection.
  • \- HCV and HIV co\-infection
  • \- HBV infected patients with decompensated cirrhosis and hepatocellular carcinoma

Outcomes

Primary Outcomes

Not specified

Similar Trials